A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study (Q36980484)
Jump to navigation
Jump to search
scientific article published on 21 February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study |
scientific article published on 21 February 2013 |
Statements
A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study (English)
Michael W Sill
Edgar Fischer
Kathleen M Darcy
Robert S Mannel
Krishnansu S Tewari
Parviz Hanjani
Jason A Wilken
Andrew K Godwin
Russell J Schilder
Meenakshi Singh
Nita J Maihle
21 February 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference